ArticleLaryngoscope investigative otolaryngology2026
Patterns of Influenza Vaccination in Head and Neck Cancer Patients in the United States.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patterns of Influenza Vaccination in Head and Neck Cancer Patients in the United States.Laryngoscope investigative otolaryngology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: The American Society of Clinical Oncology recommends routine influenza vaccination for cancer patients. Lack of influenza vaccination may lead to increased infection incidence, increased infection severity, and delays in cancer care. Vaccine uptake among head and neck patients is unknown. Methods: We performed a retrospective cohort analysis using the SEER-Medicare database for patients above age 65 with head and neck cancer diagnosed between 2013 and 2018. Results: Among 32,155 patients, 32.5% received vaccination in the year before diagnosis and 32.1% in the year after diagnosis. Analyses revealed a significant increase in vaccination at the time of diagnosis and fewer vaccinations in the 3 months afterward. Various factors were associated with decreased odds of receiving vaccination, including Black and AAPI race/ethnicity, male gender, and regional and distant metastasis. Conclusions: Vaccination uptake is suboptimal in patients with head and neck cancer, underscoring the need for targeted interventions to enhance preventive care to improve outcomes in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.